TAK · Categories · Upgrades
TAK - Analyst upgrades
Takeda Pharmaceutical Company Limited (TAK) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for TAK
- Takeda Pharma upgraded by BernsteinBernstein upgraded Takeda Pharma from Mkt Perform to Outperform
- Takeda Pharma upgraded by Morgan StanleyMorgan Stanley upgraded Takeda Pharma from Equal-Weight to Overweight
- Takeda Pharma upgraded by BofA Securities with a new price targetBofA Securities upgraded Takeda Pharma from Neutral to Buy and set a new price target of $20.00
- Takeda Pharma upgraded by Cowen with a new price targetCowen upgraded Takeda Pharma from Market Perform to Outperform and set a new price target of $24.00 from $21.00 previously